Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 798
interventional 568
Observational 208
Registry 22

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 182
Drug|placebo 110
Other 69
Biological 42
Procedure 30
Device 27
Biological|placebo 22
Behavioral 17
Dietary Supplement 16
Dietary Supplement|placebo 9
Drug|Procedure 6
Biological|Drug 5
Diagnostic Test 5
Other|placebo 4
Dietary Supplement|Other 3
Drug|Other 3
Behavioral|Other 2
Biological|Procedure 2
Device|Drug 2
Device|Other 2
Dietary Supplement|Drug 2
Behavioral|Drug 1
Behavioral|Procedure 1
Device|Diagnostic Test|Procedure 1
Device|placebo 1
Dietary Supplement|Drug|Other 1
Dietary Supplement|Drug|placebo 1
Drug|Genetic 1
Procedure|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 138
NA 36
France 33
Canada 27
China 22
United Kingdom 21
Israel 18
United States|Canada 17
Japan 16
Spain 10
Denmark 9
Netherlands 9
Germany 8
Italy 8
Australia 7
Belgium 7
Korea, Republic of 6
Belgium|France 5
Switzerland 4
Brazil 3
Ireland 3
Norway 3
Austria|Germany 2
Hong Kong 2
Sweden 2
United States|Australia 2
United States|Belgium|Germany|Israel|Netherlands 2
United States|Canada|Puerto Rico 2
United States|United Kingdom 2
Argentina|Australia|Brazil|Canada|New Zealand|Russian Federation|Switzerland|Ukraine|United Kingdom 1
Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Czech Republic|Denmark|France|Germany|Hungary|Israel|Netherlands|Poland|South Africa|Sweden|United Kingdom 1
Australia|Belgium|France 1
Australia|Bulgaria|Czechia|Estonia|Hungary|India|Italy|Korea, Republic of|Latvia|Malaysia|New Zealand|Poland|Romania|Russian Federation|Serbia|South Africa|Turkey|Ukraine 1
Australia|United States|Austria|Belgium|Brazil|Canada|Chile|Czechia|Estonia|Finland|Germany|Hungary|Israel|Italy|Latvia|New Zealand|Poland|Romania|Russian Federation|Ukraine 1
Austria 1
Austria|Belgium|Czech Republic|Denmark|Finland|France|Germany|Greece|Ireland|Italy|Norway|Portugal|Slovakia|Spain|Sweden|Switzerland|United Kingdom 1
Austria|Belgium|France|Germany|Israel|Italy|Netherlands|Spain 1
Austria|Belgium|France|Germany|Netherlands 1
Austria|Belgium|Germany|Hungary|Netherlands 1
Austria|France|Germany|Italy 1
Austria|Germany|Hungary|Poland|Russian Federation|Spain|Ukraine 1
Belgium|Bulgaria|Croatia|Czech Republic|France|Germany|Hungary|Netherlands|Romania 1
Belgium|Bulgaria|Czech Republic|France|Hungary|Latvia|Netherlands|Norway|Poland|Romania|Serbia|Sweden|Ukraine 1
Belgium|Czech Republic|France|Germany|Hungary|Poland|Romania|Russian Federation|United Kingdom 1
Belgium|Czechia|Denmark|France|Germany|Italy|Netherlands|Portugal|Slovakia|Spain|Sweden|United Kingdom 1
Belgium|Finland|Netherlands 1
Belgium|France|Germany 1
Belgium|France|Israel|Italy|Netherlands|Poland|South Africa|Spain|United Kingdom 1
Belgium|Germany 1
Belgium|Hungary|Netherlands 1
Belgium|Netherlands 1
Belgium|Poland|Spain|United Kingdom 1
Belgium|South Africa|United States|Argentina|Australia|Austria|Bosnia and Herzegovina|Brazil|Bulgaria|Canada|Chile|China|Colombia|Croatia|Czechia|Denmark|Egypt|Estonia|France|Germany|Greece|Hong Kong|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Serbia|Singapore|Slovakia|Slovenia|Spain|Sweden|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
Canada|Ireland|Israel|Spain 1
Canada|Israel 1
Canada|United Kingdom 1
Croatia|Poland|South Africa|Ukraine|United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Czechia|Estonia|France|Germany|Hungary|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Mexico|Netherlands|New Zealand|Romania|Russian Federation|Serbia|Slovakia|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
Czech Republic 1
Czech Republic|France|Germany|Hungary|Israel|Italy|Japan|Netherlands|Poland|Slovakia|Ukraine 1
Czechia 1
Czechia|France|Germany|Hungary|Israel|Italy|Japan|Netherlands|Poland|Slovakia|Ukraine 1
Czechia|Hungary|Japan|Poland 1
Denmark|United States|Argentina|Australia|Austria|Belgium|Bosnia and Herzegovina|Italy|Brazil|Bulgaria|Canada|Chile|China|Colombia|Croatia|Czechia|Egypt|Estonia|France|Germany|Greece|Hong Kong|Hungary|Ireland|Israel|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Serbia|Singapore|Slovakia|Slovenia|South Africa|Spain|Sweden|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
France|Germany|Hungary|Israel|Italy|Poland|Russian Federation 1
France|Spain 1
France|United States|Belgium|Germany|Hungary|Spain 1
Germany|Hungary|United States|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Croatia|Czechia|Denmark|France|Iceland|Ireland|Israel|Japan|Korea, Republic of|Netherlands|New Zealand|Poland|Russian Federation|Serbia|South Africa|Spain|United Kingdom 1
Germany|Switzerland 1
Germany|United Kingdom 1
Hungary|United States|Australia|Belgium|Brazil|Bulgaria|Canada|Croatia|France|Germany|Iceland|Israel|Japan|Korea, Republic of|Netherlands|New Zealand|Poland|Russian Federation|Serbia|South Africa|Spain|United Kingdom 1
Hungary|United States|Belgium|Canada|Czechia|France|Italy|Poland 1
India 1
Ireland|Israel 1
Israel|Italy|Spain 1
Israel|United States|Argentina|Australia|Belgium|Bosnia and Herzegovina|Brazil|Bulgaria|Canada|Croatia|Czechia|Denmark|Estonia|Germany|Hungary|Italy|Japan|Korea, Republic of|Lithuania|Mexico|Netherlands|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Sweden|Taiwan|Turkey|Ukraine|United Kingdom 1
Japan|Korea, Republic of 1
Poland|United States|Austria|Belgium|Canada|Czechia|Denmark|France|Germany|Hungary|Israel|Italy|Netherlands|Puerto Rico|Romania|Slovakia|Spain|Switzerland|Ukraine|United Kingdom 1
Poland|United States|Canada|Germany|Italy 1
Russian Federation 1
Slovakia|United States|Belgium|Czech Republic|France|Hungary|Italy|Netherlands|Poland|South Africa|Spain|United Kingdom 1
Slovenia 1
South Africa|Switzerland 1
Switzerland|United States|France|Netherlands 1
United States|Argentina|Australia|Austria|Belarus|Belgium|Bosnia and Herzegovina|Brazil|Bulgaria|Canada|Chile|China|Hong Kong|Colombia|Croatia|Czechia|Estonia|Germany|Greece|Ireland|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Norway|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belarus|Belgium|Bosnia and Herzegovina|Bulgaria|Canada|Chile|China|Colombia|Croatia|Czechia|Denmark|Egypt|Estonia|France|Germany|Greece|Hong Kong|Ireland|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Norway|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belarus|Belgium|Bosnia and Herzegovina|Bulgaria|Canada|Chile|China|Colombia|Croatia|Czechia|Denmark|Egypt|Estonia|France|Germany|Greece|Ireland|Israel|Switzerland|Italy|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Taiwan|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belarus|Belgium|Bosnia and Herzegovina|Bulgaria|Canada|China|Croatia|Czechia|Denmark|Finland|France|Georgia|Germany|Greece|Hungary|Ireland|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Mexico|Moldova, Republic of|Netherlands|Norway|Poland|Portugal|Romania|Russian Federation|Saudi Arabia|Serbia|Slovakia|Slovenia|South Africa|Spain|Sweden|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belarus|Belgium|Bosnia and Herzegovina|Bulgaria|Canada|China|Croatia|Czechia|Denmark|Finland|France|Georgia|Germany|Greece|Hungary|Ireland|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Mexico|Moldova, Republic of|Netherlands|Norway|Poland|Portugal|Romania|Russian Federation|Taiwan|Saudi Arabia|Serbia|Slovakia|Slovenia|South Africa|Spain|Sweden|Switzerland|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Bosnia and Herzegovina|Brazil|Bulgaria|Canada|Chile|China|Colombia|Croatia|Czechia|Denmark|Egypt|Estonia|Germany|Greece|Hong Kong|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Serbia|Singapore|Slovakia|Slovenia|South Africa|Spain|Sweden|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Bosnia and Herzegovina|Bulgaria|Canada|Colombia|Croatia|Czechia|Estonia|France|Germany|Greece|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Lebanon|Lithuania|Mexico|Netherlands|New Zealand|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Switzerland|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Bosnia and Herzegovina|Bulgaria|Colombia|Croatia|Estonia|Germany|Greece|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Lebanon|Lithuania|Mexico|Netherlands|New Zealand|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Croatia|Czechia|Estonia|France|Germany|Hungary|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Mexico|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Sweden|Switzerland|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|China|Croatia|Czechia|France|Germany|Hungary|India|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Mexico|Netherlands|Poland|Puerto Rico|Romania|Russian Federation|Serbia|Slovakia|Spain|Sweden|Switzerland|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Czechia|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Netherlands|Poland|Romania|Russian Federation|Turkey|Ukraine 1
United States|Argentina|Australia|Austria|Belgium|Bulgaria|Canada|Croatia|Czechia|France|Georgia|Germany|Greece|Hong Kong|Hungary|Iceland|India|Ireland|Israel|Italy|Japan|Korea, Republic of|Malaysia|Mexico|Netherlands|New Zealand|Norway|Russian Federation|Poland|Portugal|Romania|Serbia|Singapore|Slovakia|South Africa|Spain|Sri Lanka|Sweden|Switzerland|Taiwan|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Bulgaria|Canada|Croatia|Czechia|France|Georgia|Germany|Greece|Hong Kong|Hungary|Iceland|India|Ireland|Israel|Italy|Japan|Korea, Republic of|Malaysia|Mexico|Netherlands|New Zealand|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Sri Lanka|Sweden|Switzerland|Taiwan|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belarus|Belgium|Bosnia and Herzegovina|Bulgaria|Canada|Croatia|Czechia|Denmark|France|Germany|Ireland|Israel|Italy|Korea, Republic of|Latvia|Mexico|Moldova, Republic of|Norway|Poland|Romania|Russian Federation|Saudi Arabia|Spain|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Belgium|Bosnia and Herzegovina|Bulgaria|Colombia|Estonia|Greece|Hungary|Ireland|Japan|Korea, Republic of|Lebanon|Mexico|New Zealand|Portugal|Slovakia|Spain|Turkey|Ukraine 1
United States|Argentina|France|Germany|Italy|Poland|Russian Federation|Ukraine 1
United States|Australia|Austria|Belarus|Belgium|Bosnia and Herzegovina|Brazil|Canada|Chile|China|Colombia|Croatia|Czechia|France|Georgia|Germany|Greece|Hungary|Israel|Italy|Japan|Jordan|Korea, Republic of|Latvia|Lebanon|Lithuania|Malaysia|Netherlands|New Zealand|North Macedonia|Poland|Portugal|Puerto Rico|Russian Federation|Saudi Arabia|Serbia|Slovakia|Spain|Switzerland|Taiwan|Tunisia|Turkey|Ukraine|United Kingdom 1
United States|Australia|Austria|Belarus|Belgium|Bulgaria|Canada|Czechia|Denmark|Estonia|Georgia|Germany|Hong Kong|Hungary|Israel|Italy|Latvia|Lithuania|New Zealand|Norway|Poland|Russian Federation|Serbia|Singapore|Slovenia|South Africa|Spain|Sweden|Ukraine 1
United States|Australia|Austria|Belarus|Belgium|Bulgaria|Canada|Czechia|Denmark|Estonia|Germany|Hungary|Israel|Italy|New Zealand|Norway|Poland|Russian Federation|Serbia|Singapore|Slovenia|South Africa|Spain|Ukraine 1
United States|Australia|Austria|Belgium|Bosnia and Herzegovina|Canada|Croatia|Czechia|Georgia|Germany|Hungary|Italy|Korea, Republic of|Lebanon|Poland|Russian Federation|Saudi Arabia|Serbia|Slovakia|South Africa|Spain|Switzerland|Tunisia|Turkey|Ukraine|United Arab Emirates 1
United States|Australia|Austria|Belgium|Brazil|Canada|Czech Republic|Denmark|France|Germany|Hungary|Iceland|Ireland|Israel|Japan|Korea, Republic of|Netherlands|New Zealand|Poland|Serbia|South Africa|Spain|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Canada|Czechia|Estonia|Germany|Hungary|Israel|Italy|Latvia|New Zealand|Poland|Romania|Russian Federation|Ukraine 1
United States|Australia|Austria|Belgium|Canada|Czechia|Denmark|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Netherlands|New Zealand|Norway|Poland|Slovakia|South Africa|Spain|Sweden|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|France|Germany|Israel|Netherlands|New Zealand|Spain|United Kingdom 1
United States|Australia|Austria|Bulgaria|Canada|China|Finland|France|Georgia|Germany|Greece|Hungary|Israel|Korea, Republic of|Lithuania|Netherlands|Poland|Portugal|Russian Federation|Serbia|Slovakia|Slovenia|South Africa|Spain|Sweden|Taiwan|Turkey|Ukraine 1
United States|Australia|Austria|Bulgaria|Canada|Croatia|Czech Republic|France|Germany|Greece|Hungary|Israel|Japan|Korea, Republic of|Netherlands|South Africa|Spain|Ukraine 1
United States|Australia|Austria|Bulgaria|Canada|Czech Republic|France|Germany|Greece|Hungary|Israel|Japan|Korea, Republic of|Netherlands|South Africa|Spain|Ukraine 1
United States|Australia|Austria|Bulgaria|Canada|Czechia|France|Germany|Greece|Hungary|Israel|Japan|Korea, Republic of|Netherlands|South Africa|Spain|Ukraine 1
United States|Australia|Austria|Bulgaria|Croatia|France|Georgia|Germany|Greece|Hungary|Israel|Korea, Republic of|Poland|Portugal|Romania|Russian Federation|Serbia|South Africa|Spain|Ukraine|United Kingdom 1
United States|Australia|Austria|Croatia|Germany|Israel|Italy|Japan|Lithuania|Netherlands|Poland|Romania|Russian Federation|Serbia|South Africa|United Kingdom 1
United States|Australia|Belgium|Bosnia and Herzegovina|Brazil|Bulgaria|Canada|Czechia|Denmark|Estonia|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Lithuania|Mexico|Netherlands|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Sweden|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Australia|Belgium|Brazil|Bulgaria|Canada|Czechia|France|Germany|Hungary|Italy|Korea, Republic of|Netherlands|Poland|Russian Federation|Serbia|Spain|United Kingdom 1
United States|Australia|Belgium|Brazil|Canada|China|Croatia|Czechia|Denmark|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Poland|Portugal|Romania|Russian Federation|Slovakia|Spain|Sweden|Switzerland|Taiwan|Ukraine|United Kingdom 1
United States|Australia|Belgium|Brazil|Canada|Czech Republic|Denmark|France|Germany|Greece|Hungary|Ireland|Israel|Italy|New Zealand|Romania|Switzerland|United Kingdom 1
United States|Australia|Belgium|Brazil|Canada|Czech Republic|Denmark|France|Germany|Hungary|Ireland|Israel|Italy|New Zealand|Switzerland|United Kingdom 1
United States|Australia|Belgium|Canada|Czechia|Denmark|France|Germany|Hungary|Israel|Italy|Netherlands|New Zealand|Norway|Poland|Puerto Rico|Romania|Slovakia|Spain|United Kingdom 1
United States|Australia|Belgium|Canada|Czechia|Germany|Hungary|Israel|Korea, Republic of|Malaysia 1
United States|Australia|Belgium|Canada|Czechia|Hungary|Japan|Netherlands|Poland|Romania|Russian Federation|Switzerland|Ukraine|United Kingdom 1
United States|Australia|Belgium|Canada|Denmark|France|Germany|Hungary|Italy|Netherlands|Poland|South Africa|Spain|Sweden|United Kingdom 1
United States|Australia|Bulgaria|Canada|Czechia|Israel|New Zealand|Poland|Serbia|Slovakia 1
United States|Australia|Canada 1
United States|Australia|Canada|Hungary|Slovakia 1
United States|Australia|Canada|New Zealand 1
United States|Australia|New Zealand 1
United States|Austria|Belgium|Bulgaria|Canada|France|Germany|Japan|Korea, Republic of|Netherlands|Norway|Poland|Serbia|Slovakia|South Africa|Spain 1
United States|Austria|Belgium|Canada|Czechia|Denmark|France|Germany|Hungary|Netherlands|Switzerland|United Kingdom 1
United States|Austria|Belgium|Canada|Czechia|France|Germany|Hungary|Israel|Italy|Spain|Ukraine|United Kingdom 1
United States|Austria|Belgium|Canada|Czechia|France|Germany|Hungary|Israel|Italy|Spain|United Kingdom 1
United States|Austria|Belgium|Canada|Denmark|France|Germany|Greece|Israel|Netherlands|Norway|Portugal|Spain|Sweden|United Kingdom 1
United States|Austria|Belgium|Canada|Denmark|France|Germany|Italy|Netherlands|Norway|Spain|Sweden|Switzerland|United Kingdom 1
United States|Austria|Belgium|Canada|France|Germany|Italy|Netherlands 1
United States|Austria|Belgium|Canada|France|Germany|Italy|Netherlands|Spain|Sweden|Switzerland|United Kingdom 1
United States|Austria|Belgium|Canada|France|Germany|Japan|Korea, Republic of|Netherlands|Norway|Poland|Serbia|Slovakia|South Africa|Spain 1
United States|Austria|Belgium|Germany 1
United States|Austria|Canada|Czechia|Germany|Hungary|Netherlands|Norway|Poland|Serbia|Slovakia|Ukraine|United Kingdom 1
United States|Austria|France|Germany|Italy|Netherlands|Spain|Sweden|United Kingdom 1
United States|Austria|France|Germany|United Kingdom 1
United States|Austria|Israel 1
United States|Belarus|Bosnia and Herzegovina|Croatia|Czechia|Germany|Greece|Israel|Poland|Russian Federation|Serbia|Turkey|Ukraine|United Kingdom 1
United States|Belgium|Bulgaria|Canada|Czechia|France|Germany|Hungary|Italy|Japan|Korea, Republic of|Poland|Romania|Russian Federation|Serbia|Ukraine|United Kingdom 1
United States|Belgium|Canada 1
United States|Belgium|Canada|Czech Republic|France|Netherlands|Poland|United Kingdom 1
United States|Belgium|Canada|Czechia|Denmark|France|Germany|Hungary|Israel|Italy|Netherlands|New Zealand|Norway|Poland|Romania|Slovakia|Spain|United Kingdom 1
United States|Belgium|Canada|Czechia|France|Germany|Hungary|Israel|Italy|Poland|Puerto Rico|Spain|United Kingdom 1
United States|Belgium|Canada|France 1
United States|Belgium|Canada|France|Germany|Hungary|Israel|Netherlands|Poland|Ukraine|United Kingdom 1
United States|Belgium|Canada|France|Germany|Poland 1
United States|Belgium|Canada|France|Hungary|Israel|Netherlands|Poland|Ukraine|United Kingdom 1
United States|Belgium|Canada|France|Hungary|Israel|Poland|Russian Federation 1
United States|Belgium|Canada|Germany|Korea, Republic of|Netherlands|Poland|Spain|United Kingdom 1
United States|Belgium|Czechia|France|Hungary|Israel|Italy|Poland|Spain 1
United States|Belgium|France|Hungary|Israel|Poland|Puerto Rico|South Africa 1
United States|Belgium|Germany|Italy 1
United States|Belgium|Germany|Sweden|United Kingdom 1
United States|Bulgaria|Czech Republic|Poland|Slovakia|Spain 1
United States|Bulgaria|Georgia|Germany|Greece|Hungary|Ireland|Israel|Italy|Moldova, Republic of|Netherlands|Poland|Russian Federation|Serbia|Spain|Ukraine|United Kingdom 1
United States|Canada|Czechia|France|Germany|Hungary|Italy|Poland|Spain 1
United States|Canada|Czechia|Israel|New Zealand|Poland|Serbia 1
United States|Canada|France|Italy|Netherlands|Spain|United Kingdom 1
United States|Canada|Germany 1
United States|Canada|Germany|Italy|Poland 1
United States|Canada|Hungary|Poland|Ukraine 1
United States|Canada|Israel|Sweden 1
United States|China|Poland|Ukraine 1
United States|Denmark|Finland|Ireland|Israel|Slovenia|United Kingdom 1
United States|France|Israel|United Kingdom 1
United States|Germany 1
United States|Germany|Israel|Netherlands 1
United States|Germany|New Zealand 1
United States|Netherlands|Switzerland 1

Sites per Study

Site_count Study_Count
1 283
2 34
3 14
4 9
5 8
6 7
7 10
8 4
9 3
10 4
11 12
12 3
13 5
14 5
15 5
17 4
18 5
19 6
20 3
21 2
22 6
23 5
24 3
25 1
26 6
27 2
28 4
29 2
30 3
31 1
33 1
34 3
35 3
37 1
38 1
39 1
40 1
41 2
43 4
44 1
45 1
48 1
49 1
50 1
51 1
52 2
56 3
57 2
58 2
61 1
63 2
65 1
66 1
70 1
72 1
73 2
75 2
78 2
81 1
84 1
88 1
91 1
92 1
97 1
98 1
100 1
103 1
107 2
108 1
111 1
112 4
114 1
115 1
116 2
127 1
128 1
134 1
137 1
138 2
140 1
141 1
143 1
147 1
163 1
177 1
178 1
182 1
189 1
193 1
194 1
206 1
219 1
220 1
224 1
239 1
263 1
281 1
306 1
307 1
326 1
336 1
410 1
430 1
436 1
460 1
463 1
482 1
505 1
511 2
529 1
540 1
604 2
660 1
661 1

Phase

Phase Study_Count
N/A 170
Phase 3 127
Phase 2 116
Phase 4 62
Phase 1 51
Phase 1/Phase 2 31
Phase 2/Phase 3 8
Early Phase 1 3

Number of Arms

Number_of_Arms Count_of_Studies
1 148
2 245
3 67
4 26
5 7
6 10
7 3
8 1
9 1
10 1
12 2
25 1
NA 56

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 9.0 2.0 1.00 2.00000 3.0000 1.00 12.0000 1.000
1st Qu. 14.5 38.5 16.00 15.00000 30.0000 88.00 102.2500 41.000
Median 20.0 74.0 23.50 25.00000 75.0000 124.00 293.0000 100.000
Mean 22.0 588362.2 41.78 37.06452 989.4649 456.50 427.4048 222.377
3rd Qu. 28.5 144.0 45.00 44.00000 158.0000 428.25 603.0000 180.000
Max. 37.0 99999999.0 264.00 216.00000 100000.0000 1900.00 3384.0000 2000.000

Trial Group Type

group_type Group_Count
Experimental 668
Active Comparator 184
Placebo Comparator 168
Other 67
NA 56
No Intervention 39
Sham Comparator 9

Intervention Model

intervention_model Study_Count
Parallel Assignment 340
Single Group Assignment 189
Crossover Assignment 22
NA 12
Factorial Assignment 3
Sequential Assignment 2

Primary Purpose

primary_purpose Study_Count
Treatment 404
Diagnostic 41
Other 32
Prevention 26
Basic Science 21
Supportive Care 20
NA 15
Health Services Research 9

Observational Studies

Studies by Country

Country Study_Count
United States 51
NA 32
France 21
Canada 12
United Kingdom 12
Korea, Republic of 10
Israel 7
Denmark 5
China 4
Germany 4
Hong Kong 4
Norway 4
United States|Canada 4
Austria 3
Italy 3
Japan 3
Australia 2
Belgium 2
Belgium|France 2
Netherlands 2
Saudi Arabia 2
Spain 2
Sweden 2
Argentina 1
Austria|Germany|Poland 1
Belarus|Kazakhstan|Russian Federation 1
Belgium|Czechia|Finland|France|Germany|Greece|Hungary|Italy|Netherlands|Portugal|Slovakia|Spain|United Kingdom 1
Germany|United Kingdom 1
Greece 1
Portugal 1
Romania 1
Switzerland 1
Taiwan|Argentina|China|Colombia|Korea, Republic of|Mexico|Russian Federation|Saudi Arabia|Singapore|Turkey 1
Turkey 1
United States|Argentina|Austria|Belgium|Canada|Denmark|Finland|France|Germany|Hungary|Ireland|Israel|Netherlands|Norway|Poland|Spain|Sweden|Switzerland|United Kingdom 1
United States|Austria|Belgium|Canada|Croatia|Denmark|Estonia|France|Germany|Greece|Ireland|Israel|Italy|Netherlands|Norway|Portugal|Slovenia|Spain|Sweden|Switzerland|United Kingdom 1
United States|Bosnia and Herzegovina|Bulgaria|Canada|Croatia|Czechia|Denmark|Estonia|France|Germany|Greece|Ireland|Israel|Italy|Lithuania|Netherlands|Portugal|Puerto Rico|Romania|Spain|Sweden|United Kingdom 1
Zambia 1

Sites per Study

Site_count Study_Count
1 149
2 16
3 5
4 5
5 1
6 1
7 2
8 3
9 1
10 1
12 1
13 2
15 2
16 1
18 1
20 1
21 1
24 2
28 1
35 1
36 1
41 1
63 1
76 1
77 1
140 1
143 1
197 1
212 1
287 1
1131 1

Enrollment Metrics

Measure Observational
Min 1.000
1st Qu 63.000
Median 150.000
Mean 3541.193
3rd Qu 436.000
Max 266890.000

Observation Model

observational_model Study_Count
Cohort 127
Case-Only 28
Case-Control 25
NA 12
Other 8
Case Control 4
Case-Crossover 1
Case Control, Natural History 1
Ecologic or Community 1
Family-Based 1

Time Perspective

time_perspective Study_Count
Prospective 155
Retrospective 27
Cross-Sectional 19
Other 4
NA 2
Longitudinal, Prospective 1

Registries

Studies by Country

Country Study_Count
United States 7
Denmark 3
Canada 2
Belgium|Netherlands 1
Czechia 1
France 1
Germany 1
Hong Kong 1
Netherlands 1
Netherlands|United Kingdom 1
Norway 1
Spain 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 14
2 1
3 2
10 1
19 1
22 1
28 1
37 1

Enrollment Metrics

Measure Registries
Min 100.000
1st Qu 328.750
Median 650.000
Mean 5135.182
3rd Qu 4057.500
Max 57053.000

Registry Model

observational_model Study_Count
Cohort 17
Case-Only 3
Family-Based 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 18
Cross-Sectional 2
Other 2

Follow-up

target_duration Study_Count
1 Year 5
5 Years 5
20 Years 2
3 Years 2
1 Day 1
16 Weeks 1
2 Years 1
24 Years 1
25 Years 1
52 Weeks 1
54 Months 1
6 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04232228 A Study to Evaluate the Impact of Care4Today® IBD, a Smart System to Facilitate the Management of Crohn’s Disease by Patients and Health Care Providers https://ClinicalTrials.gov/show/NCT04232228 Recruiting Janssen-Cilag Ltd. 2021-04-30
NCT03942120 Post-Marketing Surveillance for Crohn’s Disease Participants Treated With Stelara (Ustekinumab) https://ClinicalTrials.gov/show/NCT03942120 Recruiting Janssen Korea, Ltd., Korea 2021-11-30
NCT03397108 Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03397108 Recruiting The Hospital for Sick Children 2020-07-31
NCT03366090 Immunological Profiles in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03366090 Recruiting Rijnstate Hospital 2020-07-01
NCT03871634 Assessment of Nutritional Status of Patients With Crohn’s Disease https://ClinicalTrials.gov/show/NCT03871634 Recruiting Harokopio University 2020-12-31
NCT03819257 Anorectal Function in Perianal Crohn’s Disease https://ClinicalTrials.gov/show/NCT03819257 Completed The Leeds Teaching Hospitals NHS Trust 2020-02-22
NCT03282903 The PRognostic Effect of Environmental Factors in Crohn’s and Colitis https://ClinicalTrials.gov/show/NCT03282903 Recruiting University of Edinburgh 2020-10-31
NCT03288961 Self Screening Tool for Crohn’s Perianal Fistula https://ClinicalTrials.gov/show/NCT03288961 Recruiting Kyungpook National University Hospital 2019-12-01
NCT03266471 Cytokines and Genes in Therapeutic Response in Crohn’s Disease https://ClinicalTrials.gov/show/NCT03266471 Enrolling by invitation Vanderbilt University Medical Center 2020-10-31
NCT03262649 Manitoba Inflammatory Bowel Disease Cohort Study https://ClinicalTrials.gov/show/NCT03262649 Completed University of Manitoba 2016-03-01
NCT03223012 Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service https://ClinicalTrials.gov/show/NCT03223012 Completed AbbVie 2019-02-28
NCT03183661 A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial https://ClinicalTrials.gov/show/NCT03183661 Enrolling by invitation Anterogen Co., Ltd. 2021-03-31
NCT03143517 Fecal Calprotectin Collection Protocol https://ClinicalTrials.gov/show/NCT03143517 Completed DiaSorin Inc. 2018-08-23
NCT03096379 MRI Differentiating Gut TB and Crohn’s https://ClinicalTrials.gov/show/NCT03096379 Completed The University of Hong Kong 2018-12-30
NCT03090139 Sub-optimal Response to Anti-Tumor Necrosis Factor’s in Inflammatory Bowel Disease in Emerging Markets https://ClinicalTrials.gov/show/NCT03090139 Completed Takeda 2018-06-13
NCT03079700 Immune Modulation From Trichuris Suis https://ClinicalTrials.gov/show/NCT03079700 Completed University of Aarhus 2012-12-31
NCT03019016 Comparison of Intracorporeal and Extracorporeal Anastomoses for Minimally Invasive Right Colectomy https://ClinicalTrials.gov/show/NCT03019016 Completed Intuitive Surgical 2017-09-30
NCT02986724 A Study to Observe the Safety and Efficacy of Vedolizumab in Biologically Naive Participants With Ulcerative Colitis (UC) or Crohn´s Disease (CD) https://ClinicalTrials.gov/show/NCT02986724 Active, not recruiting Takeda 2020-08-31
NCT02926300 Long-term Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn’s Disease(CD) https://ClinicalTrials.gov/show/NCT02926300 Recruiting Kang Stem Biotech Co., Ltd. 2021-10-31
NCT02899013 Description of Perianal Lesions in a Cohort of Crohn’s Disease Patients https://ClinicalTrials.gov/show/NCT02899013 Completed Groupe Hospitalier Paris Saint Joseph 2016-12-31
NCT02896985 Observational Study Evaluating the Effectiveness of Drug Concentration to Predict the Recapture of Response in Crohn’s Disease Patients With Loss of Response ( PRADA ) https://ClinicalTrials.gov/show/NCT02896985 Completed AbbVie 2020-03-11
NCT02887287 Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn’s Disease https://ClinicalTrials.gov/show/NCT02887287 Completed Sun Yat-sen University 2015-10-31
NCT02859675 Olfactogustatory Perception, Eating Behaviour and Inflammation in Crohn’s Disease https://ClinicalTrials.gov/show/NCT02859675 Recruiting Centre Hospitalier Universitaire Dijon 2023-07-31
NCT02856763 Predictive Factors of ANTI-TNF Response in Luminal Crohn’s Disease Complicated by Abscess https://ClinicalTrials.gov/show/NCT02856763 Active, not recruiting Groupe d’Etude Therapeutique des Affections Inflammatoires Digestives 2019-01-31
NCT02851134 Search for New Genetic Mutations Major Effect in Crohn’s Disease https://ClinicalTrials.gov/show/NCT02851134 Completed University Hospital, Lille 2018-04-30
NCT02847884 IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study https://ClinicalTrials.gov/show/NCT02847884 Completed University of Alberta 2017-12-31
NCT02842450 Study of Photographs of Interest in Training to Obtain Good Reproducibility of the Diagnosis of Perianal Lesions of Crohn’s Disease Inspection in Internal Gastroenterology https://ClinicalTrials.gov/show/NCT02842450 Completed Groupe Hospitalier Paris Saint Joseph 2017-05-31
NCT02778464 Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT02778464 Completed The Royal Wolverhampton Hospitals NHS Trust 2020-01-31
NCT02770599 Improving the Health Care in Inflammatory Bowel Disease. https://ClinicalTrials.gov/show/NCT02770599 Active, not recruiting University Hospital of North Norway 2020-03-20
NCT02760836 Predictive Model of Clinical Outcomes Using Web-based Self-reporting Symptom Diary for Crohn’s Disease https://ClinicalTrials.gov/show/NCT02760836 Recruiting Kyungpook National University Hospital 2020-04-30
NCT02750800 Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie’s Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE) https://ClinicalTrials.gov/show/NCT02750800 Completed AbbVie 2018-04-03
NCT02745457 Body Composition in Children With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT02745457 Active, not recruiting Schneider Children’s Medical Center, Israel 2020-05-30
NCT02735941 Study on Cannabinoid Receptor Expression in Gastrointestinal Diseases https://ClinicalTrials.gov/show/NCT02735941 Completed Medical University of Graz 2018-07-27
NCT02727959 Inflammatory Bowel Disease in South Eastern Norway https://ClinicalTrials.gov/show/NCT02727959 Completed Oslo University Hospital 2019-12-31
NCT02709694 Imaging Biomarkers in Crohn’s Associated Spondyloarthritis https://ClinicalTrials.gov/show/NCT02709694 Active, not recruiting Hospital for Special Surgery, New York 2023-01-31
NCT02707289 Retrospective Collection of PillCam SB Movies https://ClinicalTrials.gov/show/NCT02707289 Completed Medtronic - MITG 2018-06-18
NCT02674308 Entyvio (Vedolizumab) Long Term Safety Study https://ClinicalTrials.gov/show/NCT02674308 Active, not recruiting Takeda 2021-07-22
NCT02619552 Impact of Medical Treatment on Sexual Function in Patients With Crohn’s Disease https://ClinicalTrials.gov/show/NCT02619552 Completed University of Maryland, Baltimore 2018-06-30
NCT02678052 OTIS Vedolizumab Pregnancy Exposure Registry https://ClinicalTrials.gov/show/NCT02678052 Recruiting Takeda 2022-11-30
NCT03404557 Proteomic Analysis of Crohn’s Disease Macrophages in Response or Not to AIEC https://ClinicalTrials.gov/show/NCT03404557 Completed University Hospital, Clermont-Ferrand 2019-01-18
NCT02542917 Home Versus Postal Testing for Faecal Calprotectin: a Feasibility Study https://ClinicalTrials.gov/show/NCT02542917 Completed King’s College Hospital NHS Trust 2016-07-31
NCT02539368 Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT02539368 Completed Pfizer 2018-10-31
NCT02504255 Evaluation of Immunological Markers, Inflammatory and Clinical Relapse Psychological Predictive During Crohn’s Disease https://ClinicalTrials.gov/show/NCT02504255 Completed Hospices Civils de Lyon 2014-04-30
NCT02502552 Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort https://ClinicalTrials.gov/show/NCT02502552 Completed Centre Hospitalier Universitaire de Saint Etienne 2015-10-31
NCT02466217 Phenomics in Autoimmune and Inflammatory Diseases https://ClinicalTrials.gov/show/NCT02466217 Recruiting Assistance Publique - Hôpitaux de Paris 2022-07-31
NCT02453607 The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn’s Disease https://ClinicalTrials.gov/show/NCT02453607 Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre 2019-06-30
NCT02451839 An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY) https://ClinicalTrials.gov/show/NCT02451839 Completed AbbVie 2017-12-05
NCT02399683 Immune Modulation From Trichuris Trichiura https://ClinicalTrials.gov/show/NCT02399683 Completed University of Aarhus 2012-12-31
NCT02379117 Eating Behaviour in Crohn’s Disease https://ClinicalTrials.gov/show/NCT02379117 Completed University of Nottingham 2018-01-31
NCT02322008 Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice https://ClinicalTrials.gov/show/NCT02322008 Completed Regionshospitalet Viborg, Skive 2011-03-31
NCT02316678 Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics https://ClinicalTrials.gov/show/NCT02316678 Completed University of Pennsylvania 2016-12-31
NCT02274714 Dysmenorrhea in Women With Crohn’s Disease and Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02274714 Completed University of Wisconsin, Madison 2017-01-31
NCT02193048 Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn’s Disease https://ClinicalTrials.gov/show/NCT02193048 Recruiting Ferring Pharmaceuticals 2024-08-31
NCT02161640 Vascular Dysfunction in Paediatric IBD https://ClinicalTrials.gov/show/NCT02161640 Completed Great Ormond Street Hospital for Children NHS Foundation Trust 2016-11-30
NCT02135289 The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMID https://ClinicalTrials.gov/show/NCT02135289 Completed Chinese University of Hong Kong 2019-07-31
NCT02130362 A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn’s Disease (CD) https://ClinicalTrials.gov/show/NCT02130362 Active, not recruiting AbbVie 2028-03-02
NCT02108938 Brain-Gut Interactions in Crohn’s Disease https://ClinicalTrials.gov/show/NCT02108938 Completed University of Wisconsin, Madison 2015-05-18
NCT02060318 Regulatory T-cells and Crohn’s Disease https://ClinicalTrials.gov/show/NCT02060318 Completed Hvidovre University Hospital 2016-03-07
NCT01314079 Follow-up Study of Autologous Cultured Adipose-derived Stem Cells for the Crohn’s Fistula https://ClinicalTrials.gov/show/NCT01314079 Completed Anterogen Co., Ltd. 2012-08-31
NCT01298648 Special Investigation in Patients With Crohn’s Disease (All Patients Investigation) https://ClinicalTrials.gov/show/NCT01298648 Completed AbbVie 2013-02-28
NCT01297907 Bronchial Hyperreactivity in Children With Crohn Disease https://ClinicalTrials.gov/show/NCT01297907 Completed Rambam Health Care Campus 2009-12-31
NCT01289366 Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD) https://ClinicalTrials.gov/show/NCT01289366 Completed University of Erlangen-Nürnberg Medical School 2011-08-31
NCT02057016 Long-term Scheduled Therapy With Infliximab in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT02057016 Completed Catholic University of the Sacred Heart 2014-12-31
NCT02054533 Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT02054533 Completed Icahn School of Medicine at Mount Sinai 2017-06-30
NCT01966744 Self-Management Assistance for Recommended Treatment (SMART) Portal https://ClinicalTrials.gov/show/NCT01966744 Completed Children’s Hospital Medical Center, Cincinnati 2016-06-30
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions https://ClinicalTrials.gov/show/NCT01931644 Recruiting Sanguine Biosciences 2025-08-31
NCT01916161 The Influence of Information Sources on Knowledge and Anxiety in Inflammatory Bowel Disease Patients https://ClinicalTrials.gov/show/NCT01916161 Completed National Health Service, United Kingdom 2016-02-29
NCT01891214 Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn’s Disease https://ClinicalTrials.gov/show/NCT01891214 Completed Rennes University Hospital 2016-04-30
NCT01861288 Deep Endoscopic Remission Assessed by a Surrogate Biomarker in Patients With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT01861288 Completed Herlev Hospital 2016-09-05
NCT01860846 Anti-Tumor Necrosis Factor (TNF) Treatments, Work Productivity and Quality of Life in Crohn’s Disease https://ClinicalTrials.gov/show/NCT01860846 Completed AbbVie 2016-02-29
NCT01813500 Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients https://ClinicalTrials.gov/show/NCT01813500 Completed Boston Medical Center 2015-09-30
NCT01797224 OTIS Autoimmune Diseases in Pregnancy Project https://ClinicalTrials.gov/show/NCT01797224 Recruiting University of California, San Diego 2020-01-31
NCT01793376 Development of Niv Score of Capsule Endoscopy in Patients With Crohn’s (CECDAIic) https://ClinicalTrials.gov/show/NCT01793376 Completed Medtronic - MITG 2016-02-29
NCT01768858 Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn’s Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT01768858 Completed AbbVie 2017-08-13
NCT01759264 An Observational Study of Fecal Calprotectin as Clinical Tool in Monitoring Moderate-to-severe Crohn’s Disease on Adalimumab Induction Therapy: a KoRean Experience (FAIR) https://ClinicalTrials.gov/show/NCT01759264 Completed AbbVie 2014-05-31
NCT01749813 Specific Carbohydrate Diet as Maintenance Therapy in Crohn’s Disease https://ClinicalTrials.gov/show/NCT01749813 Completed Stanford University 2015-05-31
NCT01736046 Comparison of Standard and Low Dose CT Enterography for Crohn’s Disease https://ClinicalTrials.gov/show/NCT01736046 Completed University of British Columbia 2015-01-31
NCT01720368 OPERA Database - Crohn’s Protocol https://ClinicalTrials.gov/show/NCT01720368 Completed Dartmouth-Hitchcock Medical Center 2015-03-31
NCT01705522 Multimodal Approach in IBD Patients https://ClinicalTrials.gov/show/NCT01705522 Recruiting Clinical Hospital Colentina 2019-09-30
NCT01676324 FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD) https://ClinicalTrials.gov/show/NCT01676324 Completed University of British Columbia 2013-03-31
NCT01666626 Ultrasound Stiffness Imaging in Crohn’s Disease https://ClinicalTrials.gov/show/NCT01666626 Completed University of Michigan 2015-07-31
NCT01573078 Psychology of Crohn’s Disease https://ClinicalTrials.gov/show/NCT01573078 Completed University of British Columbia 2015-01-28
NCT01555437 Assessment of Capsule Endoscopy Scoring Index (CESI), Harvey-Bradshaw Index (HBI) and Biological Markers in Small Bowel Crohn’s Disease (SBCD) https://ClinicalTrials.gov/show/NCT01555437 Completed Shanghai Jiao Tong University School of Medicine 2011-02-28
NCT01545063 CAre of Patients With PArenteral Nutrition At Home https://ClinicalTrials.gov/show/NCT01545063 Completed KU Leuven 2013-04-30
NCT01517516 Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest. https://ClinicalTrials.gov/show/NCT01517516 Completed University of California, Los Angeles 2015-07-31
NCT01476995 Prognostic Indicators as Provided by the EPIC ClearView https://ClinicalTrials.gov/show/NCT01476995 Completed Epic Research & Diagnostics, Inc. 2011-06-30
NCT01473927 Significance of Ficolin 2 in the Determination of Serological Activity in Chronic Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT01473927 Completed University of Bern 2013-02-28
NCT01468090 Disease Course in an IBD Cohort in the Era of Biological Treatment https://ClinicalTrials.gov/show/NCT01468090 Completed Hvidovre University Hospital 2014-06-30
NCT01464333 Special Investigation (Long-term Investigation) in Patients With Crohn’s Disease https://ClinicalTrials.gov/show/NCT01464333 Completed AbbVie 2018-03-31
NCT01428115 Reveal the Level of Anxiety in Patients With Crohn’s Disease Receiving Adalimumab https://ClinicalTrials.gov/show/NCT01428115 Completed AbbVie 2013-10-31
NCT01405105 Exacerbating Factors in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT01405105 Completed Dallas VA Medical Center 2012-06-30
NCT01392365 Development of a Prediction Model for Differential Diagnosis Between Intestinal Tuberculosis and Crohn’s Disease https://ClinicalTrials.gov/show/NCT01392365 Completed Asan Medical Center 2015-02-28
NCT01365767 Contrast Ultrasound of the Small Intestine in Patients With Crohns Disease https://ClinicalTrials.gov/show/NCT01365767 Completed Regionshospitalet Silkeborg 2011-09-30
NCT01364896 Anal Human Papillomavirus in Inflammatory Bowel Disease Study https://ClinicalTrials.gov/show/NCT01364896 Completed University of Pittsburgh 2014-01-31
NCT01363427 Retrospective Data Analysis in Crohn’s Disease https://ClinicalTrials.gov/show/NCT01363427 Completed Ferring Pharmaceuticals 2010-05-31
NCT01349920 Biomarkers of Intestinal Mucosal Healing in Crohn’s Disease (P08143) https://ClinicalTrials.gov/show/NCT01349920 Completed Merck Sharp & Dohme Corp. 2015-09-28
NCT01349504 Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT01349504 Completed Beth Israel Deaconess Medical Center 2012-12-31
NCT01331551 Mesalamine and Reproductive Health Study https://ClinicalTrials.gov/show/NCT01331551 Completed Harvard School of Public Health 2018-08-31
NCT04306939 Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study https://ClinicalTrials.gov/show/NCT04306939 Recruiting University of Pittsburgh 2025-12-01
NCT04297566 MICISPORT Survey : Questionnaire https://ClinicalTrials.gov/show/NCT04297566 Active, not recruiting University Hospital, Montpellier 2020-04-01
NCT04272788 Association of Breg and Treg With the Clinical Effects of Infliximab in the Treatment of Patients With Crohn’s Disease https://ClinicalTrials.gov/show/NCT04272788 Completed Second Affiliated Hospital of Wenzhou Medical University 2019-09-29
NCT04191707 Metabolomic Markers of Fatigue in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT04191707 Completed Corporacion Parc Tauli 2019-12-01
NCT04151420 Real Life Remote Monitoring of Mild, Moderate and Severe Infectious Complications in IBD by Patient Reported Assessment https://ClinicalTrials.gov/show/NCT04151420 Recruiting Maastricht University Medical Center 2021-11-30
NCT04135027 Study of Factors and Mechanisms Influencing the Effects of Treatments in Crohn’s Disease Patients https://ClinicalTrials.gov/show/NCT04135027 Recruiting Second Affiliated Hospital, School of Medicine, Zhejiang University 2020-12-31
NCT04131504 Precision Crohn’s Disease Management Utilizing Predictive Protein Panels (ENvISION) https://ClinicalTrials.gov/show/NCT04131504 Recruiting Children’s Hospital Medical Center, Cincinnati 2021-02-28
NCT04119635 Pediatric Penetrating Crohn’s Disease https://ClinicalTrials.gov/show/NCT04119635 Completed University Hospital, Montpellier 2018-09-01
NCT04113733 Combinatorial Single Cell Strategies for a Crohn’s Disease Gut Cell Atlas https://ClinicalTrials.gov/show/NCT04113733 Enrolling by invitation Vanderbilt University Medical Center 2022-12-31
NCT04088773 Biomarkers of Intestinal Fibrosis in Small Bowel Crohn’s Disease https://ClinicalTrials.gov/show/NCT04088773 Recruiting Children’s Hospital Medical Center, Cincinnati 2021-09-30
NCT04079335 A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Relapse in Patients With IBD https://ClinicalTrials.gov/show/NCT04079335 Recruiting Chinese University of Hong Kong 2021-01-28
NCT04002180 Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn’s Disease] https://ClinicalTrials.gov/show/NCT04002180 Recruiting Takeda 2023-10-31
NCT03994224 A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Response to Biological Therapy in Patients With CD https://ClinicalTrials.gov/show/NCT03994224 Recruiting Chinese University of Hong Kong 2021-02-18
NCT03981939 Perianal Fistula (PAF) Validation and Burden of Illness Study https://ClinicalTrials.gov/show/NCT03981939 Completed Takeda 2019-12-17
NCT03964883 Infliximab Blood Test in Crohn’s Disease https://ClinicalTrials.gov/show/NCT03964883 Completed Groupe Hospitalier Paris Saint Joseph 2018-03-01
NCT03952364 The PRECIOUS Study: Predicting Crohn’s & ColitIs Outcomes in the United States https://ClinicalTrials.gov/show/NCT03952364 Recruiting PredictImmune Ltd 2021-06-30
NCT03950726 Ileocolic Resection for Complex Crohn’s Disease https://ClinicalTrials.gov/show/NCT03950726 Completed University of Roma La Sapienza 2017-12-31
NCT03941184 Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity https://ClinicalTrials.gov/show/NCT03941184 Recruiting Mayo Clinic 2020-12-31
NCT03939117 The IUSS Crohn’s Study: A Feasibility Study https://ClinicalTrials.gov/show/NCT03939117 Completed Portsmouth Hospitals NHS Trust 2020-03-09
NCT03915262 Exocrine Pancreatic Insufficiency’s Prevalence in Active Crohn’s Disease https://ClinicalTrials.gov/show/NCT03915262 Recruiting Hospices Civils de Lyon 2020-12-02
NCT03890445 Real-world Study of Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Patients With Crohn´s Disease https://ClinicalTrials.gov/show/NCT03890445 Recruiting Sandoz 2020-05-08
NCT03884439 Infliximab Biosimilar “Pfizer” Drug Use Investigation (Crohn’s Disease or Ulcerative Colitis) https://ClinicalTrials.gov/show/NCT03884439 Recruiting Pfizer 2023-03-13
NCT03878498 Management of Anal Fistula of Crohn Disease https://ClinicalTrials.gov/show/NCT03878498 Active, not recruiting Rennes University Hospital 2019-09-19
NCT03846778 Risk Factors of Complications After Ileocolic Resection for Crohn Disease According to the Comprehensive Complication Index https://ClinicalTrials.gov/show/NCT03846778 Active, not recruiting University Hospital, Montpellier 2020-03-01
NCT03841045 Unraveling a Potential Connection Between Bilirubin Metabolism, Gut Microbiota and Inflammatory Bowel Diseases https://ClinicalTrials.gov/show/NCT03841045 Recruiting Soroka University Medical Center 2020-12-31
NCT03836612 Healthcare Resource Utilisation, Common Mental Health Problems, and Infections in People With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03836612 Completed Momentum Data 2019-09-01
NCT03835780 The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study https://ClinicalTrials.gov/show/NCT03835780 Completed Momentum Data 2019-08-01
NCT03817983 MRE as a Screening Tool for axSpA in IBD https://ClinicalTrials.gov/show/NCT03817983 Recruiting Cambridge University Hospitals NHS Foundation Trust 2020-02-08
NCT03801928 Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03801928 Completed Pfizer 2020-02-07
NCT03776825 Permacol Paste in Perianal Crohn’s Disease https://ClinicalTrials.gov/show/NCT03776825 Recruiting Istituto Clinico Humanitas 2019-10-01
NCT03774485 Myoelectric GutPrint-Crohn’s Disease https://ClinicalTrials.gov/show/NCT03774485 Recruiting Stanford University 2020-06-30
NCT03757065 Cell Surface Marker Expression in Autoimmune Diseases https://ClinicalTrials.gov/show/NCT03757065 Enrolling by invitation Alpine Immune Sciences, Inc. 2020-03-31
NCT01218360 Observational Study of Disease Severity in Participants Diagnosed With Crohn’s Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn’s Disease (Protocol P06484) https://ClinicalTrials.gov/show/NCT01218360 Completed Merck Sharp & Dohme Corp. 2015-01-31
NCT03710486 A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn’s Disease (CD) Participants https://ClinicalTrials.gov/show/NCT03710486 Recruiting Takeda 2021-09-30
NCT03681652 Post-Operative Crohn’s Disease Outcome in Children https://ClinicalTrials.gov/show/NCT03681652 Recruiting Schneider Children’s Medical Center, Israel 2022-12-31
NCT03668249 A Study to Characterize Multidimensional Model to Predict the Course of Crohn’s Disease (CD) https://ClinicalTrials.gov/show/NCT03668249 Completed Takeda 2019-09-16
NCT03646708 Response Assessment in SB CD https://ClinicalTrials.gov/show/NCT03646708 Recruiting Washington University School of Medicine 2023-05-30
NCT03640637 The Role of PET/MRI in the Diagnosis and Treatment of Children and Adolescents With Inflammatory Bowel Diseases https://ClinicalTrials.gov/show/NCT03640637 Enrolling by invitation Odense University Hospital 2020-12-31
NCT03606499 Real-world Effectiveness of Ustekinumab in Participants Suffering From Crohn’s Disease With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases https://ClinicalTrials.gov/show/NCT03606499 Recruiting Janssen Cilag S.A.S. 2021-04-30
NCT03589183 Gut Microbiome in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03589183 Recruiting Kyunghee University Medical Center 2028-03-31
NCT03565432 Sick Leave, Work Disability and Quality of Life in Korean Patients With Inflammatory Bowel Diseases https://ClinicalTrials.gov/show/NCT03565432 Active, not recruiting Kyunghee University Medical Center 2019-07-30
NCT03553472 Identifying Young Inflammatory Bowel Disease Patients at Risk for Herpes Zoster https://ClinicalTrials.gov/show/NCT03553472 Completed University of Wisconsin, Madison 2019-05-31
NCT03532932 A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life Practice https://ClinicalTrials.gov/show/NCT03532932 Recruiting Takeda 2021-07-15
NCT03496818 Effect of SB CD on Chylomicron https://ClinicalTrials.gov/show/NCT03496818 Recruiting Washington University School of Medicine 2020-04-30
NCT03495973 Prospective Observational Study on Ustekinumab (Stelara) Assessing Efficacy and Healthcare Resource Utilization in Crohn’s Disease https://ClinicalTrials.gov/show/NCT03495973 Active, not recruiting Janssen-Cilag Ltd. 2020-09-30
NCT03492944 Contrast Enhanced Ultrasound in Human Crohn’s Disease-Lumason https://ClinicalTrials.gov/show/NCT03492944 Recruiting Children’s Hospital Medical Center, Cincinnati 2022-01-31
NCT03488030 A Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) https://ClinicalTrials.gov/show/NCT03488030 Completed Takeda 2019-05-31
NCT03481751 Validation and Interobserver Reliability of a Simple Ultrasound Score for Crohn’s Disease https://ClinicalTrials.gov/show/NCT03481751 Active, not recruiting Haukeland University Hospital 2020-12-20
NCT03477032 FMT in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03477032 Recruiting St Vincent’s Hospital Melbourne 2019-12-31
NCT03452501 Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients https://ClinicalTrials.gov/show/NCT03452501 Active, not recruiting Hikma Pharmaceuticals LLC 2020-06-30
NCT03439826 Junior / Senior Concordance in Ultrasound Assessment of Crohn’s Disease https://ClinicalTrials.gov/show/NCT03439826 Completed Rennes University Hospital 2019-04-01
NCT01241058 Registry of Pediatric Patients Diagnosed With Crohn’s Disease in Belgium https://ClinicalTrials.gov/show/NCT01241058 Completed Belgian Society for Pediatric Gastroentrology Hepatology and Nutrition 2015-04-30
NCT01233310 Evaluation of Small Bowel Colon Capsule for Bowel Visualization in Crohn’s Disease Patients https://ClinicalTrials.gov/show/NCT01233310 Completed Medtronic - MITG 2012-04-30
NCT01183403 CE-U and MRE to Predict the Efficacy of Anti-TNF Therapy in Crohn’s Disease https://ClinicalTrials.gov/show/NCT01183403 Completed Groupe d’Etude Therapeutique des Affections Inflammatoires Digestives 2012-07-31
NCT01169207 Johns Hopkins Crohn’s Disease and Ulcerative Colitis Study https://ClinicalTrials.gov/show/NCT01169207 Active, not recruiting Johns Hopkins University 2020-12-31
NCT01140789 GWA Study in Patients With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT01140789 Recruiting Chinese University of Hong Kong 2037-04-30
NCT01105741 Metabolomic Analysis, a Potential Tool to Direct Treatment With Adalimumab in Crohn’s Disease (CD) https://ClinicalTrials.gov/show/NCT01105741 Completed University of Calgary 2013-04-30
NCT01102855 Endomicroscopy and Crohn´s Disease https://ClinicalTrials.gov/show/NCT01102855 Completed University of Erlangen-Nürnberg Medical School 2011-08-31
NCT01099111 Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI Disorders https://ClinicalTrials.gov/show/NCT01099111 Completed King Fahad Medical City 2012-01-31
NCT01086059 OTIS Autoimmune Diseases in Pregnancy Project https://ClinicalTrials.gov/show/NCT01086059 Active, not recruiting University of California, San Diego 2016-08-31
NCT01083680 Effectiveness and Safety in Patients With Crohn´s Disease in Clinical Routine https://ClinicalTrials.gov/show/NCT01083680 Completed AbbVie 2015-12-31
NCT01083121 Surveillance of Humira Injection in Korean Patients https://ClinicalTrials.gov/show/NCT01083121 Completed AbbVie 2012-06-30
NCT01032525 Monroe County Inflammatory Bowel Disease (IBD) Registry https://ClinicalTrials.gov/show/NCT01032525 Completed University of Rochester 2013-05-31
NCT00988832 An Audit of Patients With Crohn’s Disease Treated With Infliximab (P06066) https://ClinicalTrials.gov/show/NCT00988832 Completed Merck Sharp & Dohme Corp. 2010-12-31
NCT00917514 An Investigational Study to Test Usability of the Electronic Dosing Equipment Medicpen https://ClinicalTrials.gov/show/NCT00917514 Completed Medicpen AB 2010-02-28
NCT00844285 SECURE, the Cimzia ® Crohn’s Disease Post-Marketing Registry https://ClinicalTrials.gov/show/NCT00844285 Active, not recruiting UCB Pharma 2025-08-31
NCT04191395 Evolution and Treatments of Chronic Inflammatory Systemic Diseases https://ClinicalTrials.gov/show/NCT04191395 Recruiting Centre Hospitalier Universitaire de Besancon 2029-12-31
NCT03340519 Early MRI Prediction of Crohns https://ClinicalTrials.gov/show/NCT03340519 Recruiting Children’s Hospital Medical Center, Cincinnati 2020-10-31
NCT03662919 One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study https://ClinicalTrials.gov/show/NCT03662919 Recruiting Biogen 2022-06-30
NCT02580864 Bologna IBD Markers https://ClinicalTrials.gov/show/NCT02580864 Completed Nestlé 2018-10-31
NCT00816842 Plasma Citrulline Concentration in Tropical Enteropathy https://ClinicalTrials.gov/show/NCT00816842 Completed Azienda Ospedaliero-Universitaria di Parma 2008-05-31
NCT03913572 Treatment of Perianal Disease Using Adipose-derived Stem Cells https://ClinicalTrials.gov/show/NCT03913572 Recruiting University of California, San Diego 2019-09-26
NCT03285230 The French E3N Prospective Cohort Study https://ClinicalTrials.gov/show/NCT03285230 Active, not recruiting Institut National de la Santé Et de la Recherche Médicale, France 1991-11-15
NCT02839317 COmparison of MicroBiota AccordIng to Age in Crohn’s Disease (COMeBACk) https://ClinicalTrials.gov/show/NCT02839317 Recruiting University Hospital, Lille 2021-05-31
NCT02846961 Anti CT-P13 Antibody in Moderate to Severe Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT02846961 Recruiting Kyungpook National University Hospital 2018-09-30
NCT02578238 Post-Marketing Surveillance of Humira in Korean Pediatric Crohn’s Disease (CD) Patients Under the “New-Drug Re-examination” https://ClinicalTrials.gov/show/NCT02578238 Completed AbbVie 2017-05-31
NCT04372108 A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn’s Disease https://ClinicalTrials.gov/show/NCT04372108 Recruiting Janssen Scientific Affairs, LLC 2029-08-31
NCT02423512 The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness https://ClinicalTrials.gov/show/NCT02423512 Completed Icahn School of Medicine at Mount Sinai 2017-06-13
NCT01301417 Data Collection of Patients Treated With the ColonRingâ„¢ for the Creation of Circular Compression Anastomosis https://ClinicalTrials.gov/show/NCT01301417 Completed novoGI 2011-08-31
NCT04089514 A Real-world Study of Imraldi® Use https://ClinicalTrials.gov/show/NCT04089514 Recruiting Biogen 2021-06-30
NCT03897400 Ovarian Reserve in Crohn’s Disease https://ClinicalTrials.gov/show/NCT03897400 Completed Kanuni Sultan Suleyman Training and Research Hospital 2019-09-01
NCT00790543 Risk Stratification of Rapid Disease Progression in Children With Crohn’s Disease https://ClinicalTrials.gov/show/NCT00790543 Active, not recruiting Emory University 2019-12-31
NCT00727298 Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840) https://ClinicalTrials.gov/show/NCT00727298 Completed Merck Sharp & Dohme Corp. 2011-08-31
NCT00724958 Program Extension of Real Life Dosing of Remicade in Austria for Crohn’s Disease (Study P04052)(COMPLETED) https://ClinicalTrials.gov/show/NCT00724958 Completed Merck Sharp & Dohme Corp. 2010-07-31
NCT00724529 Post Marketing Surveillance of Remicade https://ClinicalTrials.gov/show/NCT00724529 Completed Janssen Korea, Ltd., Korea 2011-08-31
NCT00723905 Remicade Infusion Management Program https://ClinicalTrials.gov/show/NCT00723905 Completed Janssen Inc. 2012-10-31
NCT00723840 Assessment of the Social Cost of Crohn’s Disease: Economic and Quality of Life Aspects (Study P04560) https://ClinicalTrials.gov/show/NCT00723840 Completed Merck Sharp & Dohme Corp. 2009-12-31
NCT00711945 Growth Relapse and Outcomes With Therapy 1 https://ClinicalTrials.gov/show/NCT00711945 Completed European Society of Pediatric Gastroenterology, Hepatology and Nutrition 2014-12-31
NCT00705614 Postmarketing Safety Surveillance European Registry of Crohn’s Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035) https://ClinicalTrials.gov/show/NCT00705614 Completed Merck Sharp & Dohme Corp. 2013-02-28
NCT00676988 Study to Determine Relationship Between Serum Infliximab and Efficacy in Luminal Crohn’s Disease Patients https://ClinicalTrials.gov/show/NCT00676988 Completed University of Western Ontario, Canada 2011-04-30
NCT00606346 A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT00606346 Active, not recruiting Janssen Biotech, Inc. 2037-11-15
NCT00587210 Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel https://ClinicalTrials.gov/show/NCT00587210 Completed Mayo Clinic 2008-12-31
NCT00572780 Can CT Enteroclysis Predict the Outcome of Crohn’s Disease https://ClinicalTrials.gov/show/NCT00572780 Completed Indiana University 2012-01-31
NCT00553176 The Crohn’s Therapy, Resource, Evaluation, and Assessment Tool Registry https://ClinicalTrials.gov/show/NCT00553176 Completed Janssen Biotech, Inc. 2012-05-31
NCT00524537 A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn’s Disease (CD) https://ClinicalTrials.gov/show/NCT00524537 Completed AbbVie 2015-12-31
NCT00516776 The Innate Immune System and Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT00516776 Completed Norwegian University of Science and Technology 2017-12-31
NCT00492791 Endoscopic Severity Score of Small Bowel Crohn’s Disease With Wireless Capsule Endoscopy https://ClinicalTrials.gov/show/NCT00492791 Completed Groupe d’Etude Therapeutique des Affections Inflammatoires Digestives 2011-12-31
NCT00468455 Post-Op Quality of Life After Colorectal Surgery https://ClinicalTrials.gov/show/NCT00468455 Completed University Hospitals Cleveland Medical Center 2008-04-30
NCT00440817 An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn’s Disease. https://ClinicalTrials.gov/show/NCT00440817 Completed Centocor Ortho Biotech Services, L.L.C. 2006-08-31
NCT00434551 MACCS: Multicenter Australian CE in Patients With Suspected Crohn’s Disease Study https://ClinicalTrials.gov/show/NCT00434551 Completed Medtronic - MITG 2007-12-31
NCT00289328 Glucocorticoid-induced Osteopenia in Children https://ClinicalTrials.gov/show/NCT00289328 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NA
NCT00261976 A Long-term Safety Study of Infliximab (Remicade) https://ClinicalTrials.gov/show/NCT00261976 Completed Centocor, Inc. 2012-03-31
NCT00237055 Infectious Agents in Pediatric Crohn’s https://ClinicalTrials.gov/show/NCT00237055 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NA
NCT00222378 Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT00222378 Completed University of Miami 2012-06-30
NCT00215020 Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT00215020 Completed Boston Children’s Hospital 2006-06-30
NCT00819663 Intestinal Wall Remodeling (Infliximab Therapy) in Crohn’s Disease Patients Undergoing Serial Computed Tomography (CT) Enterography https://ClinicalTrials.gov/show/NCT00819663 Completed Mayo Clinic 2010-08-31
NCT00138879 Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn’s Disease Patients https://ClinicalTrials.gov/show/NCT00138879 Completed St Mark’s Hospital Foundation NA
NCT00061737 Quality of Life in Pediatric Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT00061737 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NA
NCT00818272 Remicade Safety Line (Crohn’s Disease)(Study P03288)(COMPLETED) https://ClinicalTrials.gov/show/NCT00818272 Completed Merck Sharp & Dohme Corp. 2010-12-31
NCT00274209 Chromoendoscopy for Ulcerative Colitis Surveillance https://ClinicalTrials.gov/show/NCT00274209 Completed Indiana University 2011-11-30

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03257345 VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03257345 Recruiting University Hospital Southampton NHS Foundation Trust 2019-09-30
NCT03251118 A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03251118 Recruiting Target PharmaSolutions, Inc. 2025-07-31
NCT03173144 Chronic Inflammatory Disease, Lifestyle and Treatment Response https://ClinicalTrials.gov/show/NCT03173144 Recruiting University of Southern Denmark 2019-03-31
NCT03131414 The IMAGINE-SPOR CIHR Chronic Disease Network https://ClinicalTrials.gov/show/NCT03131414 Recruiting Hamilton Health Sciences Corporation 2022-06-01
NCT02791854 Improving the Quality of Care for Adults With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT02791854 Enrolling by invitation Dartmouth-Hitchcock Medical Center 2030-12-31
NCT02612103 Biomarkers in Inflammatory Bowel Diseases https://ClinicalTrials.gov/show/NCT02612103 Completed Odense University Hospital 2018-01-31
NCT02326155 To Evaluate the Safety and Efficacy of Remsimaâ„¢ in Patients With Crohn’s Disease (CD) or Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT02326155 Recruiting Celltrion 2020-06-30
NCT02197780 Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD https://ClinicalTrials.gov/show/NCT02197780 Completed University Medical Center Groningen 2017-03-31
NCT02131168 Epidemiology of IBD in Hong Kong: An Inception Cohort and Follow up Study https://ClinicalTrials.gov/show/NCT02131168 Recruiting Chinese University of Hong Kong 2021-03-31
NCT02130349 IBDSL Biobank Project. Molecular Markers for Diagnosis and Therapy Response in IBD. https://ClinicalTrials.gov/show/NCT02130349 Recruiting Maastricht University Medical Center 2020-12-31
NCT02103361 Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project https://ClinicalTrials.gov/show/NCT02103361 Recruiting University of California, San Diego 2024-12-31
NCT02073526 Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT02073526 Completed Oslo University Hospital 2016-05-31
NCT04100005 A Pilot Study to Explore the Role of Gut Flora in Crohn’s Disease https://ClinicalTrials.gov/show/NCT04100005 Recruiting ProgenaBiome 2023-03-31
NCT03872726 Development and Validation of a Self-reported Objective Index of Work Disability in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03872726 Recruiting Corporacion Parc Tauli 2019-05-30
NCT03840928 AR-Power Patient Powered Research Network https://ClinicalTrials.gov/show/NCT03840928 Recruiting Global Healthy Living Foundation 2025-03-01
NCT03729674 Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs https://ClinicalTrials.gov/show/NCT03729674 Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre 2021-03-30
NCT03571373 PIBD-SETQuality; the PIBD-NET Inception Cohort and Safety Registry https://ClinicalTrials.gov/show/NCT03571373 Recruiting PIBD-Net 2020-12-31
NCT03456206 Chronic Inflammatory Disease, Lifestyle and Risk of Disease https://ClinicalTrials.gov/show/NCT03456206 Active, not recruiting University of Southern Denmark 2019-07-01
NCT02826330 Abnormal Fecal Microbiota in Healthy Subjects at High Risk for Crohn’s Disease https://ClinicalTrials.gov/show/NCT02826330 Completed University Hospital, Lille 2019-04-03
NCT02503514 Autoimmune Paradoxical Reactions in IBD Longitudinal Cohort https://ClinicalTrials.gov/show/NCT02503514 Completed University of North Carolina, Chapel Hill 2017-08-31
NCT03108326 Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease https://ClinicalTrials.gov/show/NCT03108326 Recruiting Ced Service GmbH 2023-03-31
NCT00472992 Pregnancy Exposure Registry for Tysabri® https://ClinicalTrials.gov/show/NCT00472992 Completed Biogen 2012-07-31